Haleon HLN
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$130.49M (3 inflow days, 17 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 25.2% of shares outstanding.
Largest holders
By investor type
Reported short interest has held roughly steady near 0.33% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Manulife Asset Management | Mutual Fund | 2026/Q4 | +29,005,667 | 0.8% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q4 | +27,001,462 | 0.0% |
| Mondrian Investment Partners Limited | Mutual Fund | 2026/Q4 | +17,637,434 | 0.4% |
| Cartenna Capital LP | Hedge Fund | 2026/Q4 | +13,750,000 | 0.3% |
| BlackRock | Mutual Fund | 2026/Q4 | +12,380,815 | 8.8% |
| LGT Capital Partners Ltd. | VC/PE Fund | 2026/Q4 | +10,042,014 | 0.3% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q4 | +6,214,178 | 0.2% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q4 | +6,151,286 | 0.2% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q4 | +5,600,016 | 0.1% |
| FMR | Mutual Fund | 2026/Q4 | +4,766,914 | 1.7% |
| JPMorgan Chase & Co. | Public Company | 2026/Q4 | +4,375,536 | 0.4% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q4 | +3,860,927 | 0.1% |
| Quadrature Capital Limited | Hedge Fund | 2026/Q4 | +3,777,462 | 0.1% |
| Natixis Advisors, LLC | Mutual Fund | 2026/Q4 | +3,334,734 | 0.2% |
| GAM Holding AG | Mutual Fund | 2026/Q4 | +3,265,827 | 0.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 26 Dec 2023 | Glaxosmithkline (Us) Trust | Intent to Sell (Form 144) | -8,527,104 | $8.28 | – | |
| 4 Dec 2023 | Gsk Master Grantor Trust | Intent to Sell (Form 144) | -404,599 | $8.57 | – | |
| 5 Nov 2023 | GlaxoSmithKline Employee Trust | Intent to Sell (Form 144) | -173,611 | $7.96 | – |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 14,588,479 | 0.3% | 1.0 |
| 15 Oct 2026 | 18,538,062 | 0.4% | 1.1 |
| 30 Sep 2026 | 24,837,983 | 0.6% | 1.0 |
| 15 Sep 2026 | 21,803,768 | 0.5% | 1.5 |
| 31 Aug 2026 | 15,369,691 | 0.3% | 1.8 |
| 14 Aug 2026 | 13,303,294 | 0.3% | 1.9 |
No comments yet — be the first to weigh in on HLN.
Sign in to join the discussion.